Richard Mulligan's Net Worth

$13 Million

Estimate Recalculated Jun 7, 2024 03:35PM EST

Who is Richard Mulligan?

Richard Mulligan has an estimated net worth of $13 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., Sana Biotechnology, Inc., ENZON PHARMACEUTICALS INC, Bausch Health Companies Inc., and IMCLONE SYSTEMS INC.

SEC CIK

Richard Mulligan's CIK is 0001376247

Past Insider Trading and Trends

2006 was Richard Mulligan's most active year for acquiring shares with 6 total transactions. Richard Mulligan's most active month to acquire stocks was the month of May. 2013 was Richard Mulligan's most active year for disposing of shares, totalling 14 transactions. Richard Mulligan's most active month to dispose stocks was the month of April. 2013 saw Richard Mulligan paying a total of $2,189,294.25 for 77,506 shares, this is the most they've acquired in one year. In 2013 Richard Mulligan cashed out on 89,830 shares for a total of $11,052,578.70, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOGEN INC. (BIIB) Snapshot price: $241.39

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9.98%
1.37K
15.1K
Jun 15
Form 4
+5.98%
775
13.73K
Jul 1
Form 4
+7.38%
890
12.95K
Jun 3
Form 4
+10.59%
1.16K
12.06K
Jun 19
Form 4
+8.77%
880
10.91K
Jun 12
Form 4
+11.76%
1.05K
10.03K
Jun 7
Form 4
+13.43%
1.06K
8.95K
Jun 8
Form 4
+9.66%
695
7.89K
Jun 10
Form 4
+13.75%
870
7.2K
Jun 12
Form 4
+26.00%
1.3K
6.33K
Jun 12
Form 4
+148.51%
3K
$53.43
$160,290.00
5.02K
Scheduled
May 29
Form 4
0
$147.06
-$7,111,095.84
2.02K
Scheduled
May 28
Form 4
-58.94%
-2.90K
$176.88
-$512,952.00
2.02K
Scheduled
Mar 22
Form 4
-61.86%
-7.98K
$175.38
-$1,399,526.61
4.92K
Scheduled
Mar 13
Form 4
+18.57%
2.02K
12.9K
Jun 8
Form 4
+36.34%
2.9K
10.88K
Jun 1
Form 4
+255.46%
5.74K
7.98K
Jun 9
Form 4
2.25K
2.25K
Jun 10
Form 3
0
0
No matching records found

Sana Biotechnology, Inc. (SANA) Snapshot price: $6.135

Head SanaX

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 6
Form 4
0
0
Mar 2
Form 4
0
0
Mar 3
Form 3
0
0
No matching records found

ENZON PHARMACEUTICALS INC (ENZN) Snapshot price: $0.09625

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jan 2
Form 4
+61.43%
18.67K
49.06K
Jul 2
Form 4
0
0
Jan 3
Form 4
+73.93%
12.92K
30.39K
Jul 1
Form 4
0
0
Jan 3
Form 4
+67.51%
7.04K
17.48K
Jul 1
Form 4
0
0
Jan 4
Form 4
10.43K
10.43K
May 21
Form 3
0
0
No matching records found

Bausch Health Companies Inc. (BHC) Snapshot price: $8.125

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
0
0
Form 4/A
+53.65%
35.36K
101.27K
May 17
Form 4
+79.57%
29.2K
65.91K
May 19
Form 4
+1,484.12%
34.39K
36.7K
Jun 24
Form 4
2.32K
2.32K
May 13
Form 3
0
0
No matching records found

IMCLONE SYSTEMS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Sep 20
Form 3
0
0
No matching records found